Help:Adding open license text to Wikipedia/how to
Appearance
Immedica Pharma AB
Immedica Pharma is a pharmaceutical company, headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care products. Immedica was founded in 2018 by its management and the investment firm Impilo. Immedica’s capabilities cover marketing and sales, compliance, pharmacovigilance, quality assurance, regulatory, medical affairs and market access, as well as a global distribution network serving patients in more than 50 countries. Immedica is fully dedicated to helping those living with diseases which have a large unmet medical need. Immedica’s therapeutic areas are primarily within genetic & metabolic diseases and hematology & oncology.